Please login to the form below

Not currently logged in
Email:
Password:

Hill & Knowlton appoints Daniel McIntyre

Hill & Knowlton has appointed Daniel McIntyre as worldwide head of healthcare to drive the company's growth strategy in this sector

Hill & Knowlton (H&K) has appointed Daniel McIntyre as worldwide head of healthcare. McIntyre will drive the company's growth strategy in healthcare, integrating its assets to address the complex communications needs of client organisations active throughout the sector.

McIntyre joins H&K from integrated marketing communications consultancy Global Prairie where he was partner. His experience includes product marketing, corporate reputation, issues management, international public affairs and public policy. 

He has more than 30 years of working in the industry for companies including Fleishman Hillard, Wyeth, MeadWestvaco, Pharmacia, Bayer, American Home Products and Hoffman La Roche.

Based in New York, McIntyre will report to Paul Taafe, chairman and global CEO. Taafe said: "Dan's experience is key as H&K responds to the needs of our growing healthcare roster. Our clients face some of the toughest challenges globally such as litigation, regulatory oversight, risk communications, reimbursement and market access. These require an increasingly holisitic view of the healthcare world."

McIntyre said: "As opportunities expand for healthcare organisations worldwide so do the complexities of societal expectations and obligations inherent in the industry. No firm is better positioned than H&K to advise and counsel in this healthcare landscape."

1st June 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

Theresa Heggie
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
Theresa Heggie talks about the biotech’s 16-year path to market, and the promise of its ‘gene silencing’ medicines...
patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...

Infographics